MedTrace Logo

Serial Therapeutic and Antifungal Monitoring Protocol

NCT02163889 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2018-08-20

No results posted yet for this study

Summary

The objective of this study is to investigate T2Candida performance as a monitoring tool for post-therapy clearance of Candida compared to blood culture.

This study will collect a T2clinical specimen and companion blood culture from patients who have exhibited a positive blood culture by gram stain for yeast, and who are receiving treatment with antifungal therapy.

Conditions

  • Candidemia

Sponsors & Collaborators

  • T2 Biosystems

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02163889 on ClinicalTrials.gov